IP Library Granted Patent US 12,275,990
Granted Patent B2
US 12,275,990 · App. 17/522,434 · Granted Apr 15, 2025

Modified primers for nucleic acid amplification and detection

Inventors: Daniel Adlerstein (Trowbridge, GB); David Pearce (Trowbridge, GB); Anna Dixon (Keynsham, GB); Wellington Fakanya (Trowbridge, GB)
Assignee: Binx Health Limited
C12Q1/6853C12Q1/6823C12Q1/6848C12Q1/689
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,275,990
App. No.
17/522,434
Granted
Apr 15, 2025
Kind
B2
Abstract

A method of nucleic acid amplification involving using a first modified primer which provides protection to the amplification product from exonuclease degradation and a second primer. The method provides a double stranded nucleic acid, one strand of which is degraded by a double strand nucleic acid specific exonuclease to form a single stranded nucleic acid, which is protected from exonuclease degradation.

Claims (27)

1. A nucleic acid amplification method comprising:

amplifying a sample, with a first primer comprising at least one modified nucleotide and a second primer to provide a double stranded nucleic acid comprising a first strand comprising the first primer and a downstream amplified region and a second strand, wherein the first primer comprises SEO ID NO: 1 or 2;

incubating the double stranded nucleic acid with a 5′ to 3′ first exonuclease that hydrolyzes the second strand but not the first strand;

hybridizing a probe comprising a label to the first strand;

hydrolyzing the probe with a second exonuclease that does not hydrolyze the first strand, to produce a detectable signal from the label; and

repeating hybridization and hydrolysis of the probe to provide an increase in the detectable signal.

2. The method of claim 1 , further comprising incubating the sample with uracil-N-glycosylase to hydrolyze nucleic acid containing uracil; and performing the amplifying step with dUTP in the absence of dTTP.

3. The method of claim 1 , wherein amplifying the sample is achieved using PCR.

4. The method of claim 1 , wherein the at least one modified nucleotide comprises at least one modified nucleobase, at least one modified sugar moiety, at least one phosphorothioate linkage, or at least one phosphoramidite linkage.

5. The method of claim 4 , wherein the at least one modified nucleotide comprises at least one modified sugar moiety.

6. The method of claim 4 , wherein the at least one modified nucleotide comprises a phosphorothioate linkage.

7. The method of claim 4 , wherein the at least one modified nucleotide comprises a phosphoramidite linkage.

8. The method of claim 1 , wherein the first primer comprises at least 4 modified nucleotides.

9. The method of claim 1 , wherein the first and/or second exonuclease is T7 exonuclease.

10. The method of claim 1 , wherein the label is an electrochemical label.

11. The method of claim 10 , wherein the electrochemical label is a ferrocene label.

12. The method of claim 1 , wherein the second primer comprises the other of SEQ ID NOS: 1 or 2.

13. A method of detecting a genetic target, the method comprising:

annealing a primer comprising SEQ ID NO: 1 or 2 to nucleic acid in a sample, the primer comprising at least one modified nucleotide;

extending the primer to create a copy of the genetic target;

hybridizing a first labeled probe to the copy; and

digesting the first labeled probe with an exonuclease to release a label from the probe and generate a detectable signal while the at least one modified nucleotide prevents the exonuclease from digesting the copy.

14. The method of claim 13 , further comprising annealing a second labeled probe to the copy and digesting the second labeled probe to increase a signal-to-noise ratio of the detectable signal.

15. The method of claim 13 , wherein the at least one modified nucleotide comprises at least one modified nucleobase, at least one modified sugar moiety, at least one phosphorothioate linkage, or at least one phosphoramidite linkage.

16. The method of claim 13 , wherein the exonuclease is T7 exonuclease.

17. The method of claim 13 , wherein the label is an electrochemical label.

18. The method of claim 17 , wherein the electrochemical label is a ferrocene label.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 26, 2022
From: ADLERSTEIN, DANIEL; PEARCE, DAVID; DIXON, ANNA; FAKANYA, WELLINGTON
To: ATLAS GENETICS LIMITED
Reel/Frame 060593/0330 →
CHANGE OF NAME Recorded Mar 9, 2022
From: ATLAS GENETICS LIMITED
To: BINX HEALTH LIMITED
Reel/Frame 059210/0373 →
Priority Claims (1)
GB 1312995 · Jul 19, 2013 · national
Continuity (2)
Continuation 14905670
Related Publication 20220205031A1 · Jun 30, 2022
References Cited (22)
US 5418149A · Gelfand et al. · 1995 [cited by applicant]
US 11180798B2 · Adlerstein · 2021 [cited by examiner]
US 20040209291A1 · Uematsu et al. · 2004 [cited by applicant]
WO WO9416090A1 · 1994 [cited by examiner]
WO WO9429279A1 · 1994 [cited by examiner]
WO 03074731A2 · 2003 [cited by applicant]
WO 2007012807A2 · 2007 [cited by applicant]
WO WO2008104791A1 · 2008 [cited by examiner]
WO 2011073675A2 · 2011 [cited by applicant]
WO 2012085591A1 · 2012 [cited by applicant]
WO 2013190328A1 · 2013 [cited by applicant]
Ono et al., “2′-Fluoro modified nucleic acids: polymerase-directed synthesis, properties and stability to analysis by matrix-assisted laser desorption/ionization mass spectrometry,” Nucleic Acids Research, vol. 25, No. … [cited by examiner]
Compton, 1991, Nucleic acid sequence-based amplification, Nature, 350(6313):91-2. [cited by applicant]
Longo, 1990, Use of uracil DNA glycosylase t control carry-over contamination in polymersase chain reactions, Gene, 93(1):125-128. [cited by applicant]
McKinlay, 2011, Genome-Wide Analysis of Nascent Transcription in [cited by applicant]
Notomi, 2000, Loop-mediated isothermal amplification of DNA, Nucleic Acids Research., 28(12):E63. [cited by applicant]
Suyama, 2007, A proportional analysis method using non-kinetic real-time PCR, J Biotechnol, 128():41-49. [cited by applicant]
Vincent, 2004, Helicase-dependent isothermal DNA amplification, EMBO Rep., 5(8):795-800. [cited by applicant]
Walker, 1992, Strand displacement amplification—an isothermal, in vitro DNA amplification technique, Nucleic Acids Res, 20(7):1691-1696. [cited by applicant]
Wang, 2012, A sensitive fluorescence strategy for telomerase detection in cancer cells based on T7 exonuclease-assisted target recycling amplification, Chem. Comm. 48:5916-5198. [cited by applicant]
Wiedmann, 1994, Ligase Chain Reaction (LCR)-Overview and Applications, PCR Methods and Applications, 3(4):S51-64. [cited by applicant]
Wroblewski, 2006, Comparison of Transcription-Mediated Amplification and PCR Assay Results for Various Genital Specimen Types for Detection of Mycoplasma genitalium, J Clin Microbiol, 44(9):3306-3312. [cited by applicant]